Univariate analysis of patients’ baseline characteristics in cohorts with iodine staining without and with ICH (n = 95)
| Patient Characteristics | No Hemorrhage (n = 58) | Hemorrhage (n = 37) | P Value |
|---|---|---|---|
| Age (mean) (SD) (yr) | 68 (12.1) | 67.7 (11.6) | .897a |
| Male sex (No.) (%) | 28 (48.3%) | 19 (51.3%) | .770b |
| History of hypertension (No.) (%) | 28 (48.3%) | 18 (48.6%) | .972b |
| History of diabetes mellitus (No.) (%) | 13 (22.4%) | 17 (45.9%) | .016b |
| History of atrial fibrillation (No.) (%) | 28 (48.3%) | 12 (32.4%) | .105b |
| MT duration (median) (IQR) (min) | 70 (55–95) | 60 (46–90) | .310c |
| Time of symptom onset to puncture (median) (IQR) (min) | 200 (144–313) | 230 (178–343) | .169c |
| ASPECTS (median) (IQR) | 8 (7–9) | 8 (7–9) | .348c |
| Baseline NIHSS (mean) (SD) | 16 (6) | 19 (7) | .067a |
| rLMC (mean) (SD) | 11.8 (4.3) | 9.4 (4.6) | .01a |
| Platelet count (median) (IQR) (109/L) | 133.8 (96.7–175.4) | 130 (100.3–167.9) | .694c |
| hs-CRP (median) (IQR) (mg I/L) | 8.4 (1.2–45.3) | 6.9 (0.5–41.2) | .904c |
| Occlusion site | |||
| ICA occlusion (No.) (%) | 15 (25%) | 13 (31.5% | .334b |
| M1 trunk occlusion (No.) (%) | 30 (51.7%) | 18 (48.6%) | .770b |
| M2 trunk occlusion (No.) (%) | 13 (22.4%) | 6 (16.2%) | .461b |
| Thrombectomy devices | |||
| Solitaired | 13 (22.4%) | 8 (21.6%) | .983b |
| Sofiae+Aperiof | 13 (22.4%) | 10 (27%) | .609b |
| Aperio | 20 (34.5%) | 14 (37.8%) | .739b |
| Sofia | 12 (20.7%) | 5 (13.5%) | .374b |
| Attempts of aspiration or stent retriever (median) (IQR) | 1 (1–1) | 1 (1-1) | .840c |
| Antiplatelet therapy (No.) (%) | 39 (67.2) | 25 (67.6) | .974b |
| Thrombolytic therapy (No.) (%) | 12 (20.7) | 7 (18.9) | .833b |
| Anticoagulant therapy (No.) (%) | 12 (20.7) | 6 (16.2) | .587b |
| Statin treatment (No.) (%) | 29 (50) | 24 (64.9) | .155b |